Phathom Pharmaceuticals, Inc. - Common Stock — movimiento de fondos (NASDAQ:PHAT) | MetaTrader

Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas

Flujo de caja de las actividades operativas -69.69 M-148.62 M-146.53 M-137.58 M-266.77 M-166.78 M -97.49 M Flujo de caja de las actividades de inversión -1.04 M-328 K-1.04 M-1.63 M-135 K-229 K -272 K Flujo de caja de las actividades financieras 114.46 M44.71 M120.04 M367.58 M182.77 M-288 K 66.35 M Flujo de caja libre -69.69 M-148.62 M-146.53 M-137.58 M-266.77 M-167 M -97.76 M

Noticias

Phathom Pharmaceuticals supera expectativas de BPA del primer trimestre de 2026

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Tops Revenue Estimates

Rocket Pharmaceuticals y Argan suben en el premercado; Two Harbors baja

Barclays mejora la calificación de Phathom Pharmaceuticals por perspectivas de ingresos

Ocugen Falls as Gene Therapy for Eye Disease Lags in Phase II Study

ImmunityBio Rises on China Nod to Bladder Cancer Combo Therapy

Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why

Mirum Completes Enrollment in Late-Stage EXPAND Study of Livmarli

COGT Rise as FDA Accepts Bezuclastinib NDA in Non-Advanced SM

Phathom Pharmaceuticals, Inc. (PHAT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Mineralys Stock Rises as FDA Accepts NDA for Hypertension Drug

Phathom Pharmaceuticals, Inc. (PHAT) Q4 2025 Earnings Call Transcript